PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
Clinical trials for PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS trials appear
Sign up with your email to follow new studies for PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug livmarli tracked for Long-Term safety in kids with rare liver disorders
Disease control Recruiting nowThis study follows 230 children with Alagille syndrome or progressive familial intrahepatic cholestasis (PFIC) who are taking Livmarli, a drug to reduce bile buildup and itching. Researchers will monitor side effects, liver function, and long-term outcomes like need for transplan…
Matched conditions: PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
Phase: PHASE4 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New registry tracks Odevixibat's Long-Term impact on rare liver disease
Disease control Recruiting nowThis registry will follow 10 people with progressive familial intrahepatic cholestasis (PFIC) in South Korea who are taking odevixibat (Bylvay). The goal is to see how safe and effective the drug is over the long term in real-world use. Researchers will track side effects and how…
Matched conditions: PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
Sponsor: Ipsen • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New registry tracks Real-World use of PFIC drug odevixibat
Disease control Recruiting nowThis registry will follow 20 people in China with progressive familial intrahepatic cholestasis (PFIC) who are taking odevixibat (Bylvay) as part of their normal care. The goal is to see how safe the drug is over the long term and how well it controls symptoms like severe itching…
Matched conditions: PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
Sponsor: Ipsen • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Baby jaundice may leave lasting marks on teeth, new study investigates
Knowledge-focused Recruiting nowThis study looks at how common tooth staining is in children who had very high bilirubin levels (jaundice) early in life. Researchers will check 120 children with certain liver conditions to see if their teeth are discolored and whether that affects their daily life. The goal is …
Matched conditions: PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Gene hunt for mysterious adult liver disease
Knowledge-focused Recruiting nowThis study is using advanced whole-genome sequencing to find hidden genetic causes of cholestatic liver disease in adults whose condition remains unexplained after standard tests. Researchers will compare the DNA of 60 affected adults to a large group of healthy controls. The goa…
Matched conditions: PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
Phase: NA • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC